Latest news

Under-the-skin (subcutaneous) injection of Tysabri (natalizumab) has been approved for UK and Ireland.

As we approach another MS awareness week after what has been a very different last 12 months, Martin Baum reflects on the impact the coronavirus lockdown has had on him.

The MHRA has granted marketing authorisation for ofatumumab (Kesimpta) for active relapsing remitting MS.

We are looking for young people with a connection to MS to join our team of MSTV reporters.

Researchers have investigated how long it takes for disease modifying drugs to be fully effective at reducing relapses and slowing progression.

Anthony Chapman is a musician who was diagnosed with MS a few years ago. In this article we find out how he started streaming his beat making on Twitch and why he is helping the MS Trust make a theme tune for our new podcast series.

Siblings Al and Bee (9 and 8 years old) have been inspired to help those affected by multiple sclerosis by taking part in Mission:100 this year.

"To forget the life where I once chose exclusion instead of inclusion would mean that I had learned nothing from a time when I chose to live MS and not life."  Martin Baum looks at how MS prepared him for lockdown.

This study compared the effectiveness of amantadine, modafinil and methylphenidate with placebo in people with MS-related fatigue.

Scarlet talks about how she learnt to manage her MS and mental health alongside the stresses of completing a university degree.

Laura is studying a PhD in Cancer Genomics and was diagnosed with MS in September 2020 following multiple hospital admissions. Here, Laura talks about how this affected her mental health and what more could be done to support other students going through the same thing.

Chris shares his experience of being diagnosed with MS at the same time as starting hormone treatment and a surgical gender transition.